Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Free Cash Flow (2020 - 2025)

PROCEPT BioRobotics has reported Free Cash Flow over the past 6 years, most recently at -$10.6 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$10.6 million for Q4 2025, up 68.47% from a year ago — trailing twelve months through Dec 2025 was -$50.0 million (up 51.79% YoY), and the annual figure for FY2025 was -$50.0 million, up 51.79%.
  • Free Cash Flow for Q4 2025 was -$10.6 million at PROCEPT BioRobotics, down from -$2.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PRCT hit a ceiling of -$2.7 million in Q3 2025 and a floor of -$38.2 million in Q1 2023.
  • Median Free Cash Flow over the past 5 years was -$18.3 million (2022), compared with a mean of -$20.2 million.
  • Biggest five-year swings in Free Cash Flow: crashed 230.2% in 2024 and later soared 85.77% in 2025.
  • PROCEPT BioRobotics' Free Cash Flow stood at -$16.9 million in 2021, then crashed by 63.78% to -$27.6 million in 2022, then soared by 63.21% to -$10.2 million in 2023, then crashed by 230.2% to -$33.6 million in 2024, then soared by 68.47% to -$10.6 million in 2025.
  • The last three reported values for Free Cash Flow were -$10.6 million (Q4 2025), -$2.7 million (Q3 2025), and -$18.3 million (Q2 2025) per Business Quant data.